369 related articles for article (PubMed ID: 15692986)
1. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S;
Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
[TBL] [Abstract][Full Text] [Related]
2. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
[TBL] [Abstract][Full Text] [Related]
3. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ
Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH
J Rheumatol; 2006 May; 33(5):985-95. PubMed ID: 16583464
[TBL] [Abstract][Full Text] [Related]
5. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
Wojtulewski JA; Schattenkirchner M; Barceló P; Le Loët X; Bevis PJ; Bluhmki E; Distel M
Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
[TBL] [Abstract][Full Text] [Related]
6. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
[TBL] [Abstract][Full Text] [Related]
7. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations.
Hanft G; Türck D; Scheuerer S; Sigmund R
Inflamm Res; 2001 Mar; 50 Suppl 1():S35-7. PubMed ID: 11339520
[TBL] [Abstract][Full Text] [Related]
8. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
Hosie J; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():39-43. PubMed ID: 8630635
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
Yocum D; Fleischmann R; Dalgin P; Caldwell J; Hall D; Roszko P
Arch Intern Med; 2000 Oct; 160(19):2947-54. PubMed ID: 11041902
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
Combe B; Vélicitat P; Garzón N; Bluhmki E
Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
[TBL] [Abstract][Full Text] [Related]
11. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV; Quartier P; Okamoto N; Foeldvari I; Spindler A; Fingerhutová Š; Antón J; Wang Z; Meszaros G; Araújo J; Liao R; Keller S; Brunner HI; Ruperto N; ;
Lancet; 2023 Aug; 402(10401):555-570. PubMed ID: 37423231
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
Lovell DJ; Giannini EH; Reiff AO; Kimura Y; Li S; Hashkes PJ; Wallace CA; Onel KB; Foell D; Wu R; Biedermann S; Hamilton JD; Radin AR
Arthritis Rheum; 2013 Sep; 65(9):2486-96. PubMed ID: 23754188
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
[TBL] [Abstract][Full Text] [Related]
14. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
Foeldvari I; Szer IS; Zemel LS; Lovell DJ; Giannini EH; Robbins JL; West CR; Steidle G; Krishnaswami S; Bloom BJ
J Rheumatol; 2009 Jan; 36(1):174-82. PubMed ID: 19012356
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
Lund B; Distel M; Bluhmki E
Scand J Rheumatol; 1998; 27(1):32-7. PubMed ID: 9506875
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis.
Reginster JY; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():17-21. PubMed ID: 8630631
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.
Jesam C; Salvatierra AM; Schwartz JL; Fuentes A; Croxatto HB
Contraception; 2014 Aug; 90(2):168-73. PubMed ID: 24909636
[TBL] [Abstract][Full Text] [Related]
18. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
Singh G; Lanes S; Triadafilopoulos G
Am J Med; 2004 Jul; 117(2):100-6. PubMed ID: 15234645
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
20. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-Pérez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalhães C; Sztajnbok F; Goldenstein-Schainberg C; Scheinberg M; Penades IC; Fischbach M; Orozco J; Hashkes PJ; Hom C; Jung L; Lepore L; Oliveira S; Wallace CA; Sigal LH; Block AJ; Covucci A; Martini A; Giannini EH; ;
Lancet; 2008 Aug; 372(9636):383-91. PubMed ID: 18632147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
